NCT01488786View on ClinicalTrials.gov

A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Blindness
Interventions
DEVICE

BrainPort Vision Device

2-3 days of training (10 hours) followed by minimum in-home use 300 minutes per month for 12 months.

Trial Locations (7)

10022

Lighthouse International, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

32503

Independence for the Blind of West Florida Inc., Pensacola

60608

The Chicago Lighthouse for People Who Are Blind and Visually Impaired, Chicago

67203

Envision, Wichita

70121

Ochsner Clinic Foundation, New Orleans

M4G 3E8

Canadian National Institute for the Blind, Toronto

All Listed Sponsors
lead

Wicab

INDUSTRY

NCT01488786 - A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind | Biotech Hunter | Biotech Hunter